$TCMD

Tactile Systems Technology (NASDAQ:TCMD) VP Sells $148,260.15 in Stock

Tactile Systems Technology (NASDAQ:TCMD) VP Kristie Burns sold 5,139 shares of company stock for $148,260.15 on January 2nd, reducing her stake by 6.63%. This transaction follows an earnings beat for the company, which reported EPS of $0.36 against an expected $0.16 and revenue of $85.76 million versus $79.31 million projected. Shares traded up 1.2% to $30.50, and institutional investors own 83.43% of the stock.

Original reporting
MarketBeat · MarketBeat
Published Jan 7, 2026, 10:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 7, 2026, 10:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tactile Systems Technology (NASDAQ:TCMD) VP Sells $148,260.15 in Stock — source image
Decision brief

The 30-second read

$TCMDNeutralMed
01

Why it matters

The insider sale occurred shortly after positive earnings, suggesting profit-taking rather than fundamental concerns.

02

Market read

The news is relevant for traders focusing on healthcare stocks, especially those with insider activity and earnings surprises.

03

What to watch

The insider sale might be for personal liquidity needs; the company's fundamentals remain strong.

Timing: Immediate, as the insider sale occurred on January 2nd and news was published on January 6th.

Background

Tactile Systems Technology reported a strong earnings beat, with EPS of $0.36 against an expected $0.16, and revenue surpassing estimates.

Company-level read

Ticker impact

$TCMDNeutralMedium confidence
Context

High relevance due to insider stock sale following strong earnings report.

Expected impact

Minimal short-term price movement expected; potential slight downward pressure due to insider selling, but offset by positive earnings.

Evidence & confidence

Insider sales can be for personal reasons and do not always indicate a negative outlook. The company's strong earnings and revenue beat suggest underlying strength.

Market effects

Potential positive sentiment in the healthcare equipment sector, as Tactile Systems operates within this space.

Limited, as the news pertains to a U.S.-listed company with high institutional ownership.

Negligible, unless the company is a market leader or significantly influences global healthcare markets.

Counterpoint

Insider selling could indicate upcoming challenges not yet reflected in earnings, warranting caution.

Key entities

  • Kristie Burns

    Senior executive involved in the stock sale.

  • Tactile Systems Technology

    Provider of medical devices and services in the healthcare sector.

Related articles

$TCMDHigh

TACTILE SYSTEMS TECHNOLOGY INC (TCMD): Results of Operations and Financial Condition

TACTILE SYSTEMS TECHNOLOGY INC (TCMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tcmd-20260810xex99d1.htm EX-99.1 Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results MINNEAPOLIS, MN, August 10th, 2026 – Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology com

$TCMDMedAI 8/10

Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

Tactile Medical (Nasdaq: TCMD) announced the full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation system. The company says it keeps the same use for chronic neuromuscular and respiratory conditions such as cystic fibrosis and bronchiectasis across ages, while adding a lighter, more adjustable vest and a redesigned controller. It also includes built-in Wi‑Fi/Bluetooth for connected care and clinician/payer data.

$DISMed

Disney, Comcast reach deal, lifting NFL Network blackout

Comcast and Disney reached an agreement to end the NFL Network blackout for Comcast Xfinity TV subscribers, resuming NFL Network and NFL RedZone in time for the 2026 season. The blackout began after their contract expired in late April. Disney owns 72% of ESPN, which took over NFL Media assets earlier this year. Terms were not disclosed.

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.